Barw Medical Journal

Sadraldin A. Braim

  1. Smart Health Tower (Raparin Branch), Karux Street, Ranya, Iraq
  2. Directorate of Health and Safety, University of Raparin, Ranya, Iraq
  3. Smart Health Tower (Raparin Branch), Karux Street, Rania, Iraq
  4. Smart Health Tower (Raparin Branch), Karukh Street, Ranya, Sulaymaniyah, Kurdistan, Iraq
Articles
3
Published
2024–2026
Corresponding
–
Reads
9,276
Downloads
2,060
Citations
3

Reads are the journal’s own count. Downloads are the journal’s own count on 8 November 2026. Citations are Crossref’s count on 8 November 2026.

Publishes with

Maria A. Rasool — 3 articles together Berun A. Abdalla — 2 articles together Dyari Q. Hamad — 2 articles together Karukh K. Mohammed — 2 articles together Sasan M. Ahmed — 2 articles together Shadan A. Hamad — 2 articles together Alan O. Younis Araz Q. Abdalla Ayman M. Mustafa Barham H. Bapir Bilal T. Mohammed Daban K. Ahmad

and 15 others across 3 articles

Articles3

Sadraldin A. Braim
  • Pilarowski–Bjornsson Syndrome with Congenital Heart Defect: A Case Report and Literature Review

    Khdir H. Hamad, Sadraldin A. Braim, Dyari Q. Hamad, Araz Q. Abdalla, Maria A. Rasool, Galawezh R. Hamad, Karukh K. Mohammed, Barham H. Bapir and 2 more

    Introduction Pilarowski–Bjornsson syndrome (PILBOS) is a rare autosomal dominant neurodevelopmental disorder caused by heterozygous variants in chromodomain helicase DNA-binding protein 1 (CHD1), a gene encoding an adenosine triphosphate (ATP)-dependent chromatin remodeler. Since its initial description in 2018, only…

    2026 1,330 reads 0 citations

    doi:10.58742/bmj.v4i1.229

    Full text PDF XML

  • Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials

    Rebaz M. Ali, Karukh K. Mohammed, Sasan M. Ahmed, Kayhan A. Najar, Mohammed Q. Mustafa, Zanyar K. Hama, Shadan A. Hamad, Maria A. Rasool and 4 more

    Introduction Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCLC) after progression on platinum-based therapy. This meta-analysis evaluated the efficacy and safety of tarlatamab as monotherapy and in combination…

    2025 5,636 reads 1 citation

    doi:10.58742/bmj.v4i1.216

    Full text PDF XML

  • Role of Inflammatory Markers in Severity, ICU Admission, and Mortality in COVID-19: A Systematic Review and Meta-analysis of 79,934 Patients

    Hiwa O. Abdullah, Sadraldin A. Braim, Maria A. Rasool, Dashne M. Abdalla, Dyari Q. Hamad, Daban K. Ahmad, Ayman M. Mustafa, Fakher Abdullah and 7 more

    Introduction Despite extensive investigations into the roles of inflammatory biomarkers in the prognosis of COVID-19 through systematic reviews and meta-analyses, they are limited by small sample sizes and focus on a specific marker. This meta-analysis investigated the role of 11 inflammatory biomarkers in severity…

    2024 2,310 reads 2 citations

    doi:10.58742/bmj.v2i2.96

    Full text PDF XML